TerrAscend Corp.

TSX:TSND.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.52 -1.61%

-$0.02 today

Market cap
$193.65M
Beta
2.04
P/E (TTM)
-2.5
EPS (TTM)
-$0.26
52W Low $0.33High $2.00

Volume 0.26M

Average 0.31M

TSND.TO Total Equity

Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.

TerrAscend Corp.TSX: TSND.TO

Total Equity · Q1 FY2026 · quarter ended Mar 2026

Total equity falls 44.9% from a year ago

Total equity stood at $91M at the end of Q1 FY2026, down 44.9% from a year earlier and down 7.9% from the prior quarter. Over 3 fiscal years it compounded at -39.0% a year.

Context

  • Total equity amounted to 16.6% of total assets at the end of Q1 FY2026, down 10.9 pp from a year earlier.
  • Total equity increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether total equity keeps falling in the next quarterly balance sheet after a -44.9% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$91M-7.9% QoQ
Last fiscal yearDec 2025
$98.84M-44.1% YoY
Year agoMar 2025
$165.11M-44.9% since
Total Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-44.9%——
1 year-44.1%——
3-year CAGR-39.0%——
5-year CAGR——
10-year CAGR——

Total Equity history

USD · from the balance sheet

Latest · FY2025
98.84M USD
Year-over-year change
-44.1%
4-year CAGR
-23.5%

Total Equity vs competitors

How TSND.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so total equity is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -44.9% is the lowest of 10, against a peer median of +26.2%.
  • Total equity amounts to 16.6% of total assets for TSND.TO, versus a peer median of 65.7%.
TSND.TO Competitors
Total Equity for TSND.TO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
WEED.TOCanopy Growth CorporationMar 2026CA$697.59M CAD+43.2%-2.8%62.4%
ACB.TOAurora Cannabis Inc.Mar 2026CA$511.83M CAD-15.9%-0.3%85.2%
OGI.TOOrganiGram Holdings Inc.Mar 2026CA$371.81M CAD-4.8%—71.3%
XLY.TOAuxly Cannabis Group Inc.Mar 2026CA$183.76M CAD+43.3%+27.5%65.7%
EPRX.TOEupraxia Pharmaceuticals Inc.Mar 2026$136.28M USD+404.1%+91.9%93.7%
CPH.TOCipher Pharmaceuticals Inc.Mar 2026$132.84M USD+26.2%+25.3%86.6%
DR.TOMedical Facilities CorporationMar 2026$117.48M USD+12.2%-4.3%42.3%
TSND.TOTerrAscend Corp.Mar 2026$91M USD-44.9%-39.0%16.6%
HLS.TOHLS Therapeutics Inc.Mar 2026$58.61M USD-12.3%-21.1%44.7%
FRX.TOFennec Pharmaceuticals Inc.Mar 2026$37.58M USD+739.1%—52.5%
Peer median (excluding TSND.TO) —+26.2%-0.3%65.7%

Competitors are the stored peer set for TSND.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents100.55M36.31M22.24M26.38M37.46M
Short-term Investments03.63M1.91M1.73M361.34K
Net Receivables12.38M22.66M19.05M27.15M16.87M
Inventory35.79M46.75M51.68M48.8M33.99M
Other Current Assets38.88M7.55M8M373.79K21.23M
Total Current Assets171.05M123.1M102.89M104.43M109.91M
Property, Plant & Equipment (Net)178.79M332.78M239.66M324.13M156.34M
Goodwill89.57M91.15M106.93M153.73M109.57M
Intangible Assets167.02M241.88M215.85M243.84M167.01M
Long-term Investments68.05M0609.48K00
Tax Assets5.01M0(609.48K)19.21M10.47M
Other Non-current Assets8.47M120.6M1.19M(238.26M)13.54M
Total Non-current Assets516.92M786.41M563.63M502.8M456.93M
Total Assets734.69M951.93M666.52M607.23M566.83M
Account Payables27.69M44.35M49.9M46.73M37.57M
Short-term Debt8.26M52.02M137.74M6.76M17.16M
Tax Payables12.15M31.31M6.3M11.53M0
Deferred Revenue1.35M3.98M4.15M5.13M3.99M
Other Current Liabilities13.49M7.55M717K887K14.21M
Total Current Liabilities65.64M139.15M207M78.53M79.79M
Long-term Debt169.74M147.17M68.9M192.58M210.36M
Deferred Tax Liabilities14.27M59.6M17.18M8.43M18.48M
Deferred Revenue (Non-current)067.1M000
Other Non-current Liabilities84.17M3.31M104.09M107.7M130.87M
Total Non-current Liabilities284.41M329.04M218.78M351.89M388.21M
Total Liabilities445.64M516.16M425.78M430.41M467.99M
Common Stock00000
Retained Earnings(312.03M)(623.86M)(928.51M)(778.51M)(863.17M)
Accumulated OCI2.8M2.1M1.8M3.01M1.98M
Other Stockholders Equity00573.16K00
Minority Interest6.78M3.22M(2.33M)(207.1K)1.53M
Total Equity289.05M435.77M240.74M176.82M98.84M
Total Debt209.67M248.25M255.7M246.18M256.49M
Net Debt166.39M298.58M233.46M219.8M219.03M

TerrAscend Corp.

TSX:TSND.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.52

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.